1.Congenital neuromuscular disease with uniform type 1 fiber complicated by brain atrophy: a case report.
Xi-Hua LI ; Jing ZHANG ; Xue-E CUI
Chinese Journal of Contemporary Pediatrics 2010;12(6):496-498
Atrophy
;
Brain
;
pathology
;
Child
;
Female
;
Humans
;
Muscle Fibers, Slow-Twitch
;
pathology
;
Neuromuscular Diseases
;
congenital
;
pathology
2.Vulvar intraepithelial neoplasia.
Ying DONG ; Xiao-ming ZHANG ; Feng ZHAO ; Cui-cui WANG ; Hui BI ; Ting LI
Chinese Journal of Pathology 2013;42(8):557-561
3.Study on preparation of sagittatoside B with epimedin B converted from cellulase.
Feng-Juan XU ; E SUN ; Zhen-Hai ZHANG ; Li CUI ; Xiao-Bin JIA
China Journal of Chinese Materia Medica 2014;39(2):235-239
To prepare sagittatoside B with epimedin B Hydrolyzed from cellulase. With the conversion ratio as the index, the effects of pH value, temperature, reaction time, dosage of enzyme and concentration of substrates on the conversion ratio were detected. L9 (3(4)) orthogonal design was adopted to optimize the preparation process. Hydrolyzed products were identified by MS, 1H-NMR, and 13C-NMR. The results showed that the optimum reaction conditions for the enzymatic hydrolysis were that the temperature was 50 degrees C, the reaction medium was pH 5.6 acetic acid-sodium acetate buffer solution, the concentration of substrates was 20 g x L(-1), the mass ratio between enzyme and substrate was 3: 5, and the relative molecular mass of the reaction product was 646.23. NMR data proved that the product was sagittatoside B. The process is simple and reliable under mild reaction conditions, thus suitable for industrial production.
Cellulase
;
metabolism
;
Drug Compounding
;
methods
;
Flavonoids
;
chemistry
;
Hydrogen-Ion Concentration
;
Hydrolysis
;
Temperature
;
Time Factors
4.Focal nonspecific ileocecum inflammation: a follow-up study of 66 cases.
Journal of Southern Medical University 2016;36(6):842-847
OBJECTIVETo investigate the natural disease course of nonspecific ileocecum inflammation (FNICI) and the possibility of early diagnosis of Crohn's disease (CD).
METHODSThe patients with an established diagnosis of FNICI at our hospital in the past 4 years were retrospectively analyzed for clinical manifestations, endoscopical, readigraphic and histopathological findings and laboratory data. The patients were followed up regularly for their outcomes.
RESULTSOur analysis included 66 patients with FNICI (with a male-to-female ratio of 34:32 and a mean age of 39 years old). The patients were followed up for 10.5 months on average, and 8 (12.1%) patients developed CD. Among these 8 patients, the initial endoscopic examination upon admission revealed ulcers involving the ileocecum valve, and biopsy results showed focal active chronic mucosal inflammation. Laboratory tests showed that the patients who finally developed CD had significantly higher erythrocyte sedimentation rate (P=0.013) and C reaction protein (P<0.01) than the patients who eventually had full recovery.
CONCLUSIONFNICI is a common lesion caused by multiple factors and has not specific endoscopic or histopathological features, which makes its definite diagnosis difficult. The patients with persistent ulcer and elevated erythrocyte sedimentation rate and C reactive protein should be closely followed up for early diagnosis of CD.
Adult ; Biopsy ; Blood Sedimentation ; C-Reactive Protein ; analysis ; Cecum ; physiopathology ; Crohn Disease ; diagnosis ; physiopathology ; Disease Progression ; Endoscopy ; Female ; Follow-Up Studies ; Humans ; Ileum ; physiopathology ; Inflammation ; physiopathology ; Male ; Retrospective Studies
5.Primary cutaneous perivascular epithelioid cell tumor: report of a case.
Yongsheng ZHANG ; Yiqun SUI ; Jian TU ; Hongxia CUI ; Fang CHEN ; Yan HOU ; Yizhong FENG
Chinese Journal of Pathology 2014;43(4):280-281
Adolescent
;
Carcinoma, Renal Cell
;
metabolism
;
pathology
;
Desmin
;
metabolism
;
Diagnosis, Differential
;
Humans
;
Leg
;
MART-1 Antigen
;
metabolism
;
Male
;
Melanoma
;
metabolism
;
pathology
;
Melanoma-Specific Antigens
;
metabolism
;
Perivascular Epithelioid Cell Neoplasms
;
metabolism
;
pathology
;
surgery
;
Sarcoma, Clear Cell
;
metabolism
;
pathology
;
Skin Neoplasms
;
metabolism
;
pathology
;
surgery
9.Efficacy of intracutaneous methylene blue injection for moderate to severe acute thoracic herpes zoster pain and prevention of postherpetic neuralgia in elderly patients.
Ji-Zheng CUI ; Jin-Wei ZHANG ; Yun ZHANG ; Zheng-Liang MA
Journal of Southern Medical University 2016;36(10):1377-1381
OBJECTIVETo evaluate the clinical efficacy of intradermal injection of methylene blue for treatment of moderate to severe acute thoracic herpes zoster and prevention of postherpetica neuralgia in elderly patients.
METHODSSixty-four elderly patients with herpes zoster were randomized to receive a 10-day course of intradermal injection of methylene blue and lidocaine plus oral valaciclovir (group A, 32 cases) and intradermal injection of lidocaine plus oral valaciclovir (group B).Herpes evaluation index, pain rating index, incidence of postherpetic neuralgia, and comprehensive therapeutic effect were compared between the two groups at 11, 30 and 60 days after the treatment.
RESULTSThe baseline characteristics were comparable between the two groups (all P>0.05). Compared with that in group B, the time for no new blister formation, blister incrustation and decrustation, and pain relief was significantly shortened in group A (P<0.05) with also obviously lower pain intensity after the treatment. The incidence of postherpetic neuralgia was significantly lower in group A than in group B at 30 days (P<0.05), but not at 60 and 90 days after the treatment. The total clinical response rate was 93.8% in group A, much higher than that in group B (62.5%, P<0.05).
CONCLUSIONIntradermal injection of methylene blue can effectively shorten the disease course, reduce the pain intensity and prevent the development of postherpetic neuralgia in elderly patients with herpes zoster.
Acyclovir ; administration & dosage ; analogs & derivatives ; therapeutic use ; Aged ; Herpes Zoster ; complications ; Humans ; Incidence ; Injections, Intradermal ; Lidocaine ; administration & dosage ; therapeutic use ; Methylene Blue ; administration & dosage ; therapeutic use ; Neuralgia, Postherpetic ; therapy ; Pain Measurement ; Valine ; administration & dosage ; analogs & derivatives ; therapeutic use
10.Effects of maternal exposure to nano-alumina during pregnancy on neurodevelopment in offspring mice.
Yong DING ; Li-na JIA ; Bin YANG ; Gang ZHANG ; Hai-yang WANG ; Wei-wei GUO ; Xiao-fang JIA ; Cui-cui GE ; Qin-li ZHANG ; Qiao NIU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2013;31(10):744-748
OBJECTIVETo observe the effects of maternal exposure to nano-alumina during pregnancy on the neurodevelopment in offspring mice.
METHODSFemale ICR mice began to be exposed to nano-alumina 10 d before mating, and the nano-alumina exposure lasted till offspring mice were born. All the female mice were randomly divided into 5 groups: solvent control group (saline), nano-carbon group (11.76 mg/ml), micro-alumina group (50 mg/ml), 50 nm alumina group (50 mg/ml), and 13 nm alumina group (50 mg/ml). All the mice were treated by nasal drip (10 µl/time) 3 times daily till offspring mice were born. Physiological indices, reflex and sensory function test, endurance test, Morris water maze test, positioning and navigation test, and open field test were used to evaluate the neurodevelopment of newborn mice.
RESULTSOn day 28, the body weight of 13 nm alumina group (16.73±4.04 g) was significantly lower than that of solvent control group (20.45±2.50 g) (P<0.01); the 13 nm alumina group had significantly delayed time to ear opening compared with the solvent control group (4.91±0.78 d vs 4.45±0.50 d, P<0.01); compared with the solvent control group, the nano-carbon group, micro-alumina group, 50 nm alumina group, and 13 nm alumina group had significantly delayed time to eruption of teeth (10.05±0.23 d vs 10.32±0.48 d, 10.75±0.45 d, 10.32±0.47 d, and 10.79±0.49 d, P<0.05 or P<0.01). On days 4 and 7 after birth, compared with the solvent control group, other groups had significantly decreased proportions of mice which passed the cliff avoidance test (P < 0.05 or P < 0.01). On days 12 and 14 after birth, compared with the solvent control group, the nano-carbon group, 50 nm alumina group, and 13 nm alumina group had significantly reduced pre-suspension time in the endurance test (P < 0.05 or P < 0.01). The Morris water maze and positioning and navigation tests showed that the 13 nm alumina group had a significantly increased 5 d incubation period compared with the solvent control group (P < 0.05); compared with the solvent control group, other groups had significantly reduced numbers of platform crossings (P < 0.05 or P < 0.01). The open field test showed that the nano-carbon group and 13 nm alumina group had reduced numbers of rearings compared with the solvent control group (P < 0.05); compared with the solvent control group, other groups had significantly reduced numbers of modifications (P < 0.01).
CONCLUSIONMaternal exposure to nano-alumina (13 nm) during pregnancy has inhibitory effects on the physical development and early behavioral development in newborn mice and can also inhibit the learning and memory abilities and adaptability to new environment in offspring mice. The neurodevelopmental toxicity of nano-alumina to newborn mice increases as the particle sizes of nano-alumina decrease, which has been demonstrated by the endurance test and number of rearings.
Aluminum Oxide ; toxicity ; Animals ; Animals, Newborn ; Behavior, Animal ; Body Weight ; Female ; Maternal Exposure ; Maze Learning ; Mice ; Mice, Inbred ICR ; Motor Activity ; Nanostructures ; toxicity ; Pregnancy